This contract involves the supply of reagents and consumables necessary for genomic detection of the Hepatitis C virus (HCV), Human Immunodeficiency Virus (HIV), and Hepatitis B virus (HBV). Additionally, it includes the establishment of a plasma bank for blood donors. Suppliers are invited to provi
Contract awarded. Originally published 1 years ago.
This contract involves the supply of equipment for obtaining blood components through the plasma apheresis technique. The buyer, the Foundation for Hemotherapy and Hemodonation of Castilla y León, is seeking suppliers who can provide high-quality equipment necessary for blood transfusion processes.
This contract is an extension of the cleaning services for the headquarters of the Foundation of Hemotherapy and Hemodonation of Castilla y León. The total value of the contract extension is €186,804.82. The Foundation is seeking a reliable supplier to continue providing high-quality cleaning servic
This contract opportunity involves the supply of systems designed to inactivate pathogens in platelet concentrates. The buyer, the Foundation for Hemotherapy and Hemodonation of Castilla y León, is seeking reliable suppliers of non-chemical disposable medical consumables and hematological products.
The KKH (Kaufmännische Krankenkasse) is seeking to establish non-exclusive discount agreements with pharmaceutical companies for specific active ingredients under the Open-House procedure. This opportunity is open to all qualified pharmaceutical companies interested in entering into discount agreeme
The Kaufmännische Krankenkasse (KKH) aims to establish discount agreements with all suitable pharmaceutical companies for the specified active ingredients under Section 130a (8) of the Social Code Book V (SGB V) through an 'Open-House' procedure. This process allows all eligible and interested pharm
This contract opportunity involves the establishment of non-exclusive discount agreements for the drug Trastuzumab, classified under ATC code L01FD01, in the regions of Lower Saxony, Bremen, and Saxony-Anhalt. The focus is on parenteral preparations made from finished medicinal products for oncology
